Jenny Levy is a litigation partner who has been with Kirkland for 25 years. She has appeared before trial courts and arbitration panels across the country. Jenny focuses on complex commercial litigation, state Attorney General litigation and investigations, pharmaceutical litigation, and product liability cases. She has litigated a wide variety of cases including consumer protection actions, public nuisance claims, allegations of fraud and misrepresentation, data breaches, breach of contract, business torts, product liability, antitrust, false claims qui tam actions, and class actions. She is currently co-lead counsel on multiple high-profile multistate litigations brought by state AGs across the country and is a leading figure in similar large, complex litigation matters. Her practice has involved a diverse array of subject matters and allegations including Public Nuisance, Consumer Protection, Lending and Loan Servicing Practices, Medicaid/Medicare fraud, drug pricing fraud and unfair competition (AWP/WAC inflation), contracts for the sale of energy, state and federal Fair Debt Collection Act (FDCA) violations, Telephone Consumer Protection Act (TCPA), collection contracts for the sale of businesses and stock purchase agreements, alleged violations of shareholder agreements, international licensing agreements, allegations of unlawful insurance practices, conspiracy, and numerous product liability cases on behalf of manufacturers of automotive products, lead products, tobacco and pharmaceuticals. Jenny is a firm leader for pro bono work and has served as the pro bono coordinator for Kirkland’s Washington, D.C., office for fifteen years.


Thought Leadership

Press Mentions

Jenny's representation of Baxter International was featured in "Lawyers: Hepatitis C outbreak doesn't happen if drug makers sell smaller anesthetic vials," from the September 12, 2011 Las Vegas Review-Journal.

Jenny is quoted in “Litigation Department of the Year,” The American Lawyer, January 2008, as a member of Kirkland’s winning Litigation Team for 2008.


Recognized by Thomson Reuters as a Stand-out Lawyer in 2023

Recognized by Law360 as a Product Liability MVP in 2022

Recognized by The American Lawyer Litigation Daily as a “Litigator of the Week” in 2021 

Recognized by Benchmark Litigation as a Future Star from 2019–2023

Recognized as one of the Minority Corporate Counsel Association’s (MCCA) Rainmakers in 2018

Recognized in The Legal 500 U.S. for Product Liability and Mass Tort Defense in both Pharmaceuticals and Medical Devices in 2012, Consumer Products in 2012 and 2013 and Toxic Tort in 2022

Profiled in The National Law Journal's annual "Champions and Visionaries" feature in July 2012

Listed as a "Washington, D.C., Super Lawyer" by Super Lawyers magazine in 2013

Recognized as one of Fortune Magazine's "Women Leaders in the Law" in 2013


Admissions & Qualifications

  • 1998New York
  • 1999District of Columbia


  • Duke University School of LawJ.D.cum laude1997

    Special Projects Editor, Law and Contemporary Problems Law Journal

  • Duke UniversityB.A.1994
    Dean's List